Search results
Ethris shares positive data with mRNA drug following new funding
Clinical Trials Arena via Yahoo Finance· 59 minutes agoGerman biotechnology company Ethris has announced initial positive Phase I data demonstrating the...
Exsilio debuts with $82M, pitching a ‘leap’ forward for genetic medicine
BioPharma Dive via Yahoo Finance· 12 hours agoAccording to Zaks, Exsilio is taking a page from that endeavor. It aims to use mRNA, as well as...
COVID is bouncing back this summer. Here’s what to know
Los Angeles Times· 3 hours agoSummer just started, but California’s not-too-surprising seasonal COVID bump is already going...
The FDA awarded a record number of review designations to mRNA vaccines in 2023
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe success of the Covid-19 messenger ribonucleic acid (mRNA) vaccines highlighted the major...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Moderna, Inc. - ...
CW39 NewsFix· 18 hours agoPomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA). Such investors are advised to contact Danielle Peyton ...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 7 days agoSubject to necessary permissions from the FDA and CDC, Novavax intends to market this updated...
Summer COVID bump intensifies in L.A. and California, fueled by FLiRT variants
LA Times via AOL· 1 day agoThe new COVID FLiRT subvariants are continuing to increase their dominance, fueling a rise in Los...
25,274 Shares in Moderna, Inc. (NASDAQ:MRNA) Bought by Los Angeles Capital Management LLC
ETF DAILY NEWS· 3 days agoLos Angeles Capital Management LLC acquired a new position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) during the 1st quarter, according to its most recent 13F ...
The FDA Now Wants Fall COVID Vaccines to Target KP.2—But Not All Manufacturers Can Pivot
Verywell Health via Yahoo News· 5 days agoLess than a week after telling COVID-19 vaccine manufacturers to target the JN.1 variant this fall,...
Market Whales and Their Recent Bets on MRNA Options - Moderna (NASDAQ:MRNA)
Benzinga· 5 days agoLoading... Loading... Investors with a lot of money to spend have taken a bullish stance on Moderna MRNA . And retail traders should know. We noticed this today when the trades ...